ArticleAmerican journal of translational research2021

The exosomal transfer of human bone marrow mesenchymal stem cell-derived miR-1913 inhibits osteosarcoma progression by targeting NRSN2.

Jihui Zhou et al.PubMed ↗Full text ↗

No numbers read from the abstract.